Drawing for SCTBIO

USPTO serial 79337464

SCTBIO

Reviewed by CopyMark Law Group

Reg. 7435168Status 700Registered
Filing date
Status date
Registration date
Jul 9, 2024
Examiner
LUEKEN, ABIGAIL JOSEPHINE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SCTBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shane Rumbaugh

Shane Rumbaugh Rumbaugh Law PLLC2400 Ansys Drive, Suite 102Canonsburg, PA 15317United States

Goods and services

ClassDescriptionStatusFirst use
039Labeling, relabeling, storage and distribution of cell therapy materialsACTIVE—
040Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, CAR-T therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, TCR-T therapy materials, namely, T cell receptor T cell-based pharmaceuticals, and CAR-NK therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals, to the order and specification of othersACTIVE—
042Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; product research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; contract research services in the field of cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 5, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 5, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 5, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 4, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 13, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 13, 2024FIMPFINAL DISPOSITION PROCESSED—
Oct 9, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 9, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 9, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 23, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 22, 2024GPNXNOTIFICATION PROCESSED BY IB—
Apr 3, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 3, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 20, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 20, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Mar 20, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 20, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 20, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 5, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 5, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 5, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 4, 2024ALIEASSIGNED TO LIE—
Feb 16, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 16, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 16, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 13, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 13, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Oct 13, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Oct 13, 2023PETGPETITION TO REVIVE-GRANTED—
Oct 13, 2023PROATEAS PETITION TO REVIVE RECEIVED—
Oct 3, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 13, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 13, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 14, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 14, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 14, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 14, 2023RFNTREFUSAL PROCESSED BY IB—
Jan 25, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 25, 2023RFRRREFUSAL PROCESSED BY MPU—
Jan 20, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 25, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 24, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 23, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 22, 2022DOCKASSIGNED TO EXAMINER—
Nov 18, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 12, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 8, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 7, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance